FDA Booster Shot Guidelines
The FDA has amended the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows:
- Pfizer - This booster may be administered at least 6 months after completion of the primary series to individuals:
- 65 years of age and older
- 18 through 64 years of age at high risk of severe COVID-19
- 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2
- Moderna - This booster may be administered at least 6 months after completion of the primary series to individuals:
- 65 years of age and older
- 18 through 64 years of age at high risk of severe COVID-19
- 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2
- Johnson & Johnson - This booster may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older.
The FDA has also authorized the use of “Mix and Match” booster doses.
This means that a single booster dose of any of the available COVID-19 vaccines may be administered as a "mix and match" booster dose following completion of primary vaccination with a different available COVID-19 vaccine. Your eligibility for booster doses is based off your primary vaccine, which you can reference above for clarification.
The COVID-19 vaccine remains our greatest weapon against this deadly virus. As new variants continue to develop and spread, it is critical that everyone get vaccinated. I encourage all those who are eligible to receive a COVID-19 vaccine booster, click the button below to schedule an appointment. If you have not yet gotten vaccinated, you can also click the button below to schedule your initial vaccine appointment. |